Researchers develop new drug for lowering bad cholesterol which needs to be taken only once a month

January 10, 2015 8:32 PM

13 0

Sanofi SA and Regeneron Pharmaceuticals have come up with an experimental drug which can help lower the amount of bad cholesterol in blood by as much as 30% if taken only once every four weeks instead of the two week interval as originally planned. The drug is called alirocumab and though the manufacturers have not yet shed light about its expected price, analysts at Barclays believe that using it could cost upto $6,000 per year.

PCSK9, a naturally occurring protein in the body, does not allow LDL cholesterol discharge from the liver to the rest of the body. Alirocumab works by blocking this protein when injected into the patient. Usually drugs to control the level of PCSK9 in the body are administered only to patients on wh...

Read more

To category page